Search - tctmd.com

Displaying 301 - 320 of 383

Sort: Relevancy | Date

Presentation

Post-ESC_15 Late-Breaking Trial Webcast: MATRIX Duration, OPTIDUAL, and PLATFORM

Presenter: Gregg W. Stone

September 15, 2015

Presentation ESC 2015

PLATFORM: IMpactsClinical outcomes of FFR-CT-guided diagnostic strategies versus usual care in patients with suspected coronary artery disease

Presenter: Pamela S. Douglas

September 01, 2015

Presentation ESC 2015

12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions

Presenter: Takeshi Kimura

September 01, 2015

Presentation ESC 2015

Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program

Presenter: Marco Valgimigli

September 01, 2015

Presentation ESC 2015

Long-term Dual Antiplatelet Therapy for 2° Prevention of Cardiovascular Events in Patients with Previous Myocardial Infarction

Presenter: Jacob A. Udell

August 31, 2015

Presentation ESC 2015

12 vs 48 months of dual antiplatelet therapy after drug-eluting stent placement: The OPTIDUAL Randomized Trial

Presenter: G?rard Helft

August 31, 2015

Presentation ESC 2015

Peri-infarct Zone Pacing to Prevent Adverse Left Ventricular Remodeling in Patients with Large Myocardial Infarction: Results from the PRomPT Trial

Presenter: Gregg W. Stone

August 30, 2015

Presentation ESC 2015

CIRCUS Study: Does Cyclosporine Improve Clinical Outcome is ST-Elevation Myocardial Infarction Patients?

Presenter: Michael Ovize

August 30, 2015

Presentation ESC 2015

Aldosterone Lethal Effects Blockade in Acute Myocardial Infarction Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-Up

Presenter: Gilles Montalescot

August 30, 2015

Presentation CCVVC 2015

Antegrade Wire Escalation Technique for Crossing CTOs – Wire Tips and Techniques

Presenter: Anvar Babaev

June 18, 2015

Presentation TVT 2015

Closing the Gap II: HIRIde

Presenter: Gregg W. Stone, Alec S. Vahanian, Francesco Maisano

June 05, 2015

Presentation TVT 2015

Closing the Gap I: COAPT, MitraFR, and RESHAPE 1 and 2

Presenter: Gregg W. Stone, Alec S. Vahanian

June 05, 2015

Presentation TVT 2015

Gaps in the Guidelines IV: Interventional Therapies

Presenter: Gregg W. Stone, Alec S. Vahanian

June 05, 2015

Presentation TVT 2015

Gaps in the Guidelines III: Surgical Therapies

Presenter: Gregg W. Stone, Alec S. Vahanian, A. Pieter Kappetein

June 05, 2015

Presentation TVT 2015

Gaps in the Guidelines II: Heart Failure and Electrical Therapies

Presenter: Gregg W. Stone, Alec S. Vahanian, Isaac George

June 05, 2015

Presentation TVT 2015

Gaps in the Guidelines I: Imaging Uncertainties

Presenter: Gregg W. Stone, Alec S. Vahanian, Robert J. Siegel

June 05, 2015

Presentation TVT 2015

ESC/EACTS 2012 and ACC/AHA 2014 Valvular Heart Disease Guidelines: Where Do They Disagree?

Presenter: Gregg W. Stone, Alec S. Vahanian, John D. Carroll

June 05, 2015

Presentation TVT 2015

ESC/EACTS 2012 and ACC/AHA 2014 Valvular Heart Disease Guidelines: Where Do They Agree?

Presenter: Gregg W. Stone, Alec S. Vahanian, Allan Schwartz

June 05, 2015

Presentation CTO 2015

MSCT: Where Could it Help for Procedural Planning

Presenter: Jeffrey W. Moses, Gerald S. Werner, Javier Escaned

February 26, 2015

Presentation

Impact of Blood Transfusions on Short and Long-term Mortality in Patients Undergoing TAVR

Presenter: R.O. Esc?rcega

October 24, 2014

Advertisement

Post-ESC_15 Late-Breaking Trial Webcast: MATRIX Duration, OPTIDUAL, and PLATFORM

PLATFORM: IMpactsClinical outcomes of FFR-CT-guided diagnostic strategies versus usual care in patients with suspected coronary artery disease

12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions

Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program

Long-term Dual Antiplatelet Therapy for 2° Prevention of Cardiovascular Events in Patients with Previous Myocardial Infarction

12 vs 48 months of dual antiplatelet therapy after drug-eluting stent placement: The OPTIDUAL Randomized Trial

Peri-infarct Zone Pacing to Prevent Adverse Left Ventricular Remodeling in Patients with Large Myocardial Infarction: Results from the PRomPT Trial

CIRCUS Study: Does Cyclosporine Improve Clinical Outcome is ST-Elevation Myocardial Infarction Patients?

Aldosterone Lethal Effects Blockade in Acute Myocardial Infarction Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-Up

Antegrade Wire Escalation Technique for Crossing CTOs – Wire Tips and Techniques

Closing the Gap II: HIRIde

Closing the Gap I: COAPT, MitraFR, and RESHAPE 1 and 2

Gaps in the Guidelines IV: Interventional Therapies

Gaps in the Guidelines III: Surgical Therapies

Gaps in the Guidelines II: Heart Failure and Electrical Therapies

Gaps in the Guidelines I: Imaging Uncertainties

ESC/EACTS 2012 and ACC/AHA 2014 Valvular Heart Disease Guidelines: Where Do They Disagree?

ESC/EACTS 2012 and ACC/AHA 2014 Valvular Heart Disease Guidelines: Where Do They Agree?

MSCT: Where Could it Help for Procedural Planning

Impact of Blood Transfusions on Short and Long-term Mortality in Patients Undergoing TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content